To understand downstream signaling pathways induced by GrK, we analyzed the proteome of differentiated human neuroblastoma SH-SY5Y cells (treated with recombinant GrK or untreated) in the presence or absence of the PAR-1 inhibitor SCH79797 (Fig. 10e). This evidence concerns the gene F2R and neuroblastoma.